This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Information about Autosomal Recessive Polycystic Kidney Disease: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Most recent studies have shown that Autosomal Recessive Polycystic Kidney Disease shares some biological mechanisms with caroli-disease, congenital-abnormality, cystic-disease--retired-, cystic-kidney-diseases, dysplasia, fetal-diseases, fibrosis, hepatic-fibrosis, hypertension-portal, hypertensive-disease, kidney-diseases, kidney-failure, kidney-failure-chronic, liver-cirrhosis, liver-diseases, nephronophthisis, pathological-dilatation, polycystic-kidney-autosomal-dominant, polycystic-kidney-diseases.
Among the many pathways, these few ones have gauged particular interests from scientists studying Autosomal Recessive Polycystic Kidney Disease, and have been seen in publications frequently: Cell Cycle, Cell Death, Cell Division, Cell Proliferation, Developmental Process, Epithelial Cell Proliferation, Excretion, Fertilization, Fluid Transport, Glomerular Filtration, Intraflagellar Transport, Ion Transport, Kidney Development, Localization, Mitosis, Pathogenesis, Regulation Of Cell Proliferation, Secretion, Spermatogenesis, Transport
Quite a number of genes have been found to play important roles in Autosomal Recessive Polycystic Kidney Disease, such as AKR1B1, AREG, BTK, EGF, EGFR, HNF1B, IFT88, MAPK1, MAPK3, PCNA, PIK3C2A, PKD1, PKD2, PKHD1, PRKD1, PRKD2. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.